Centene Corp
F:QEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Centene Corp (QEN) under the Base Case is 70.45 EUR per share.
Compared with the current market price of 62.96 EUR, the stock appears
Undervalued by 11% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Centene Does
Centene is a managed care company that runs health insurance plans for people covered by government programs. It mainly serves Medicaid members, but it also sells Medicare Advantage plans, Affordable Care Act marketplace plans, and some services for military and other public-sector groups. In simple terms, Centene helps administer medical coverage, pays providers for care, and manages the rules and paperwork around those plans.
- Headquarters
- United States of America US
- Employees
- 61 100
- IPO date
- Dec 13, 2001
Centene has no economic moat
State contracts are regularly open to competition, and members can choose among available plans. Centene’s size and name do not prevent rivals from offering competing networks, benefits, and prices.
Read the full moat analysisWhat is the Intrinsic Value of one QEN stock?
The intrinsic value for Centene Corp (QEN) under the Base Case is 70.45 EUR.
Is QEN stock undervalued or overvalued?
Compared with the current market price of 62.96 EUR, the stock appears Undervalued by 11% .
